EnVivo will continue to research and develop histone deacetylase (HDAC) inhibitors for neurodegenerative disorders such as Huntington’s, Alzheimer’s and Parkinson’s diseases under license from MethylGene. A lead compound
The Office of Generic Drugs, FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Ceftin
Under the terms of the agreement, Dynogen will become a public company through a merger with a subsidiary of Apex Bioventures. As part of the agreement, Dynogen shareholders
The collaboration will focus initially on ligament and tendon repair products that will feature coatings based on BioSET’s proprietary F2A synthetic growth factor technology. The BioSET F2A peptide
The acquisition will expand PPD’s global reach with established offices in both Russia and Ukraine. The acquisition is expected to close in the second quarter of 2008, subject
The Phase I double-blind, placebo-controlled trial has enrolled 30 healthy male and female subjects in sequential, dose-escalating cohorts. Subjects received once-daily subcutaneous injections of placebo or 40mg, 70mg
Under the terms of the agreement, ACS Biomarker has granted BG Medicine exclusive, worldwide commercial rights to pursue the development, validation, regulatory approval and commercialization of diagnostic tests
David Earp, Geron’s senior vice president of business development and chief patent counsel, said: “The claims in this patent broaden the coverage for our islet protocol beyond the
According to ActivBiotics, M40403 has shown efficacy in an animal model where oral mucositis was induced by acute irradiation. The compound has been evaluated in approximately 700 subjects
The AZ-007 Phase I clinical trial is projected to enroll approximately 40 healthy volunteers at a single US clinical center. The purpose of this trial is to assess
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.